IRVING, Texas--(BUSINESS WIRE)--Amid growing concerns of multidrug-resistant organisms, public health officials, pharmacists, physicians and other medical professionals from the city of Houston and surrounding areas met for the second annual Houston Antimicrobial Stewardship Symposium, held on Thursday, March 24, to discuss how the community can work together to help address the public health crisis of antibiotic resistance. Vizient’s Kristi Kuper helped organize the event and also gave an update on legislative activities and initiatives related to increasing antimicrobial stewardship programs.
“Antimicrobial stewardship plays a key role in the safety and quality of a patient’s care. This event is indicative of the significant increase in national interest we are seeing in hospitals and with healthcare providers around implementing programs to help improve antibiotic use,” said Kristi Kuper, PharmD, BCPS, clinical pharmacy manager for Vizient. “The Centers for Medicare & Medicaid Services (CMS) is expected to release conditions of participation in 2016 that will require a hospital to have an antibiotic stewardship program in place. Accreditation organizations are also expected to follow CMS’ lead for these types of programs.”
In 2015, Kuper participated in the White House Forum on Antibiotic Stewardship and is also leading several initiatives within Vizient related to antimicrobial stewardship. “We are working with industry groups and government agencies to leverage our expertise in antibiotic stewardship as part of our commitment to helping our members develop and implement programs that help them effectively administer and manage antibiotic prescribing in their facilities,” said Dr. Kuper.
Dr. Kuper has worked on stewardship initiatives in more than 300 hospitals across the U.S. and Puerto Rico, with a specific emphasis on resource-challenged settings. She has participated in several advisory boards on antimicrobial stewardship programs through the Institute for Healthcare Improvement and the Centers for Disease Control and Prevention-sponsored expert panels, and authored numerous publications on antimicrobial stewardship and microbial resistance testing. Additionally, Dr. Kuper is an active member of several infectious diseases medical and pharmaceutical societies and was appointed to a three-year term to serve on the Society of Health Care Epidemiology of America’s antimicrobial stewardship task force.
About Vizient, Inc.
Vizient, Inc., the largest member-owned health care company in the country, is dedicated to serving members and customers through innovative data-driven solutions, expertise and collaborative opportunities that lead to improved patient outcomes and lower costs. Vizient’s diverse membership and customer base includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks and non-acute health care providers and represents almost $100 billion in annual purchasing volume. The Vizient brand identity represents the integration of VHA Inc., University HealthSystem Consortium and Novation, which combined in 2015, as well as the recently acquired MedAssets’ Spend and Clinical Resource Management (SCM) segment, which includes Sg2. In 2016, Vizient received a World’s Most Ethical Company designation from the Ethisphere Institute. Vizient’s headquarters are in Irving, Texas, with locations in Chicago and other cities across the United States. Please visit www.vizientinc.com as well as our newsroom, blog, Twitter, LinkedIn and YouTube pages for more information about the company.